Amundi’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6M | Buy |
1,604,105
+1,274,523
| +387% | +$22.7M | 0.01% | 649 |
|
|
2025
Q1 | $7.42M | Hold |
329,582
| – | – | ﹤0.01% | 888 |
|
|
2024
Q4 | $10.9M | Buy |
329,582
+326,604
| +10,967% | +$10.8M | ﹤0.01% | 830 |
|
|
2024
Q3 | $81.6K | Buy |
+2,978
| New | +$81.6K | ﹤0.01% | 1792 |
|
|
2024
Q2 | – | Sell |
-248,483
| Closed | -$11.8M | – | 1911 |
|
|
2024
Q1 | $11.8M | Buy |
248,483
+7,112
| +3% | +$338K | 0.01% | 802 |
|
|
2023
Q4 | $17.5M | Sell |
241,371
-37,593
| -13% | -$2.72M | 0.01% | 738 |
|
|
2023
Q3 | $13.5M | Buy |
278,964
+242,860
| +673% | +$11.8M | 0.01% | 777 |
|
|
2023
Q2 | $3.22M | Sell |
36,104
-769
| -2% | -$68.6K | ﹤0.01% | 1065 |
|
|
2023
Q1 | $2.85M | Buy |
36,873
+11,035
| +43% | +$853K | ﹤0.01% | 1099 |
|
|
2022
Q4 | $1.29M | Sell |
25,838
-4,570
| -15% | -$228K | ﹤0.01% | 1263 |
|
|
2022
Q3 | $1.75M | Buy |
30,408
+26,485
| +675% | +$1.53M | ﹤0.01% | 1163 |
|
|
2022
Q2 | $178K | Hold |
3,923
| – | – | ﹤0.01% | 1371 |
|
|
2022
Q1 | $221K | Hold |
3,923
| – | – | ﹤0.01% | 1374 |
|
|
2021
Q4 | $160K | Hold |
3,923
| – | – | ﹤0.01% | 1503 |
|
|
2021
Q3 | $129K | Hold |
3,923
| – | – | ﹤0.01% | 1478 |
|
|
2021
Q2 | $248K | Buy |
+3,923
| New | +$248K | ﹤0.01% | 1335 |
|